Cetuximab

Cetuximab is a type of medicine called an antibody. It's used to treat certain types of cancer, like colorectal cancer. It works by blocking a protein that helps cancer cells grow and survive.

Brand names:Erbitux
Medication

What people taking Cetuximab report

Every report comes from a Lived member, sent anonymously.

Have you tried Cetuximab for Colorectal Cancer?

NameHow it went

About Cetuximab

What It's For

Cetuximab, sold as Erbitux, is a targeted cancer medicine given by intravenous (IV) infusion. It is used for two cancers: squamous cell carcinoma of the head and neck (cancer arising from the lining of the mouth, throat or voice box) and colorectal cancer that has spread to other parts of the body. For head and neck cancer, cetuximab can be given with radiation therapy as the first treatment for cancer that has grown locally or into nearby lymph nodes. It is also used with platinum chemotherapy and fluorouracil (another chemotherapy drug) when the cancer has come back or spread, and on its own when platinum chemotherapy has stopped working. For people with throat cancer caused by HPV (human papillomavirus) who can safely receive cisplatin (a platinum chemotherapy), a large trial found that radiation with cisplatin led to better survival than radiation with cetuximab, so cetuximab is usually reserved for people who cannot take cisplatin. For spread colorectal cancer, the tumor must be tested before treatment. Cetuximab only helps when the tumor has no mutation in RAS, a family of growth-signaling genes. It gives no benefit in RAS-mutant tumors and still causes side effects, so it is not used when the tumor carries a RAS mutation or the result is unknown. In that setting it can be combined with FOLFIRI (a chemotherapy combination of irinotecan, fluorouracil and leucovorin) as a first treatment, with irinotecan, or given alone after other chemotherapy. A separate use is for colorectal tumors with a specific mutation in the BRAF gene, called V600E. Here cetuximab is paired with encorafenib (Braftovi), a pill that blocks the faulty BRAF protein, either together with fluorouracil-based chemotherapy, which can be a first treatment, or without chemotherapy after earlier treatment.

How It Works

Many cancer cells carry a receptor on their surface called EGFR (epidermal growth factor receptor). When growth signals attach to it, EGFR switches on a chain of messages inside the cell that tells it to grow and divide. Cetuximab is a monoclonal antibody, a lab-made immune protein, that latches onto EGFR and blocks those signals, which can slow tumor growth and help radiation or chemotherapy work. The signal passes through a protein called RAS. If RAS itself is mutated, it stays switched on regardless of EGFR, which is why blocking EGFR does not help RAS-mutant colorectal cancer. Normal skin and hair follicles also rely on EGFR, which explains why skin problems are the most familiar side effect.

Dosage & Administration

Cetuximab is given as an IV infusion at a cancer center. The dose is calculated from body surface area (a measure based on height and weight), so it is individual. The first infusion usually takes about two hours. After that, it is given either weekly over about an hour or every two weeks over about two hours, depending on the regimen. With radiation, treatment starts a week before radiation and continues weekly through the six to seven weeks of radiation. An antihistamine is given beforehand to reduce the chance of an infusion reaction, and people are observed for at least an hour after each infusion. When cetuximab is combined with radiation or chemotherapy, it is finished about an hour before the other treatment. For advanced cancer, it usually continues as long as it is controlling the cancer and side effects are manageable. Doses are delayed or reduced for severe rash.

Side Effects

An acne-like rash on the face, scalp, chest and back affects most people, usually within the first two weeks. It can be accompanied by dry, itchy or cracked skin, painful swelling around the nails and changes to hair or eyelashes. The rash often lasts for weeks after treatment ends. Skin care plans, sometimes including antibiotics or creams, help keep it under control, and limiting sun exposure during treatment and for two months afterward matters. Tiredness, headache, diarrhea, nausea, low appetite and infections are also common; with radiation, mouth and throat soreness can be more intense. Infusion reactions are the main immediate danger. Most serious ones happen during the first infusion, even with an antihistamine, and can cause sudden breathing trouble, hoarseness or a drop in blood pressure; the infusion team watches for this and stops the drug if it is severe. A reaction can also start hours later, so fever, chills or breathing problems after going home should be reported to the care team right away; severe trouble breathing, throat swelling or fainting is an emergency (call 911). New or worsening cough, chest pain or shortness of breath also needs a call to the care team right away, because cetuximab can rarely cause lung inflammation. Red or irritated eyes or blurred vision, and skin that blisters or peels, should be reported promptly.

Interactions & Warnings

Before starting, tell the care team about any history of tick bites or allergy to red meat. Both are linked to alpha-gal, a sugar in cetuximab that some people already have antibodies to, which raises the risk of a severe allergic reaction. A blood test for alpha-gal antibodies may be offered, though a negative result does not rule out a reaction. Cetuximab carries a boxed warning from the US Food and Drug Administration (FDA), the strongest label warning. Besides serious infusion reactions, cardiac arrest or sudden death has occurred in people with head and neck cancer receiving it with radiation or with platinum chemotherapy and fluorouracil. People with coronary artery disease, heart failure or abnormal heart rhythms should discuss this risk. Cetuximab can also lower magnesium, along with calcium and potassium, which can affect the heart and muscles, so these are checked regularly during treatment and for at least eight weeks after it ends. Cetuximab can harm a developing baby. People who could become pregnant should use effective contraception during treatment and for two months after the last dose, and should not breastfeed during that time.

What to Expect

Treatment means regular trips to an infusion center, often weekly, with blood tests for magnesium and other minerals along the way. The rash usually appears early and may need its own plan with the care team or a dermatologist; it tends to ease once treatment stops, though that can take weeks. How well cetuximab works varies widely. With radiation for head and neck cancer, it is a defined course of six to seven weeks. For cancer that has spread, it is not a cure but aims to shrink or hold back the tumor and extend life, and scans every few months show whether it is still working. If the cancer grows or side effects become too hard to manage, the team will discuss changing treatment.

Questions to Ask Your Doctor

  1. 1.Why is cetuximab the right choice for my cancer, and how does it compare with options like cisplatin or other targeted drugs?
  2. 2.For colorectal cancer, what did my tumor's RAS and BRAF testing show?
  3. 3.Should I be tested for alpha-gal antibodies, given my history of tick bites or reactions to red meat?
  4. 4.How should I care for my skin and nails, and when should I call about the rash?
  5. 5.How will we know whether the treatment is working, and how long might I stay on it?

Last reviewed • Oct 2026

Educational content, not medical advice.